Toxic epidermal necrolysis treated with low-dose intravenous immunoglobulin: immunohistochemical study of Fas and Fas-ligand expression.
Ito
K
K
Hara
H
H
Okada
T
T
Shimojima
H
H
Suzuki
H
H
D000368:Aged; D000369:Aged, 80 and over; D004817:Epidermis / Q000378:metabolism; D053222:Fas Ligand Protein; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage*; D008562:Membrane Glycoproteins / Q000378:metabolism; D013262:Stevens-Johnson Syndrome / Q000378:metabolism / Q000628:therapy*; D019014:fas Receptor / Q000378:metabolism*
C505661:FASLG protein, human; D053222:Fas Ligand Protein; D016756:Immunoglobulins, Intravenous; D008562:Membrane Glycoproteins; D019014:fas Receptor